In the decade following the introduction of CAPD by Popovich et al (I) substantial improvements have been made in the management of CAPD peritonitis. This review summarizes the significant advances in the prevention, diagnosis and treatment of CAPD peritonitis in the first 10 years of CAPD therapy (1976–1986) and highlights additional areas where management protocols can be improved further.
PopovichR.P., MoncriefJ.W., DecherdJ.B.The definition of a novel portable/wearable equilibrium peritoneal dialysis technique (abstr).Am Soc Artif Internal Organs1976; 5: 64.
2.
SlingeneyerA., MionC., DespauxE.Use of bacteriologic filter in the prevention of peritonitis associated with peritoneal dialysis: Long term clinical results in intermittent and continuous ambulatory peritoneal dialysis. In: AtkinsR.C. eds. Peritoneal Dialysis.Churchill-Livingstone: Edinburgh, 1981: 301–312.
3.
RubinJ., RogerW A., TaylorH.M.Peritonitis during continuous ambulatory peritoneal dialysis.Ann Int Med1980; 92: 7–13.
4.
NolphK.D., SorkinM.I., RubinJ.Continuous ambulatory peritoneal dialysis: Three year experience at one centre.Ann Int Med1980; 92: 609–613.
WilliamsD.L., BrowderI.W., DiluzioN.R.Immunotherapeutic modification of escherichia-coli induced experimental peritonitis and bacteremia by glucan.Surgery1983; 93: 448–454.
18.
CarozziS., DiMaioA., LamperiS.The use of intravenous human SRK immunoglobulin in the prophylaxis of recurrent bacterial peritonitis in CAPD.Perit Dial Bull1984; 4: SII.
19.
NolphK.D.A reminder of the less ions learned from the multicentre UV trial.Perit Dial Bull1985; 3: 203–204.
VasS.I., LowE.S., LayneS.Microbiological diagnostic approaches to peritonitis in CAPD patients. In: AtkinsR.C. eds. Peritoneal Dialysis.Churchill-Livingstone, 1981: 264–271.
22.
CowardR.A., MallickN.P.Infection in peritoneal dialysis.Lancet1981; i: 54–56.
23.
AokalR., RamosJ.M., FrancisD.M.A.Peritonitis in continuous ambulatory peritoneal dialysis.Lancet1982; ii: 1388–1391.
24.
HurleyR.M., WrightD.W., WilsonO.W.Detection of leucocytes in peritoneal effluent by test strip.Lancet1981; i: 437–438.
25.
VasS.I.Microbiological aspects of peritonitis.Perit Dial Bull1981; 1: S11–14.
26.
BastaniB., WesterveltF.B., FreerK.E.Treatment of peritonitis with two intraperitoneal (IP) doses of vancomycinin CAPD patients.Kidney Int1986; 29: 229.
27.
FeinP., HurtadoH., JordenA.New modified schedule for antibiotic delivery in CAPD.Kidney Int1986; 29: 231.
28.
OreopoulosD.O., WilliamsP., KhannaR.Treatment of peritonitis.Perit Dial Bull1981: I: S17–S19.
MaiorcaR., CantaluppiA., CancariniO.C.Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis.Lancet1983; ii: 642–644.
31.
OtaK.Clinical experience in CAPD using flame-lock connecting device -a group study.Perit Dial Bull1984; 4: S47.
32.
Report of the National CAPD Registry of the National Institutes of Health. Distributed 1.1.84.
33.
A randomized multicentre clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis.A multicentre study group.Perit Dial Bull1985: I: 19–24.
34.
HamiltonR.W.Reduction of peritonitis frequency by the Dupont sterile connection device.Abstr ASAIO1985; 14: 37.
35.
PopovichR.P., MoncriefJ.W., NolphK.D.Continuous ambulatory peritoneal dialysis.Ann Int Med1978; 88–94.
